[
  {
    "ts": null,
    "headline": "Jim Cramer’s Take on Pfizer Inc. (PFE): Bold Predictions for the Future",
    "summary": "We recently compiled a list of the Jim Cramer’s Bold Predictions About These 10 Healthcare Stocks. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other healthcare stocks Jim Cramer has made bold predictions about. Healthcare has been one of Jim Cramer’s favorite topics lately. The […]",
    "url": "https://finnhub.io/api/news?id=9170b3ed2d54ef04052a86a29fbdb0fd87a0cd9d2de556951ea76dcbb51ddde9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735753848,
      "headline": "Jim Cramer’s Take on Pfizer Inc. (PFE): Bold Predictions for the Future",
      "id": 132231546,
      "image": "https://media.zenfs.com/en/insidermonkey.com/a6c6a869a7c2c92171425bdb9b9fb0f6",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "We recently compiled a list of the Jim Cramer’s Bold Predictions About These 10 Healthcare Stocks. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other healthcare stocks Jim Cramer has made bold predictions about. Healthcare has been one of Jim Cramer’s favorite topics lately. The […]",
      "url": "https://finnhub.io/api/news?id=9170b3ed2d54ef04052a86a29fbdb0fd87a0cd9d2de556951ea76dcbb51ddde9"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer's 2025 Comeback: What's Driving Growth",
    "summary": "Pfizer plans to achieve $4 billion in savings, invest in key areas like oncology and vaccines, and project double-digit EPS growth. Read more on PFE stock here.",
    "url": "https://finnhub.io/api/news?id=e57fd332ccd391b5d0c94cc57b5d0054cfa1b67004fe6029f2c8ff26b0384177",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735722900,
      "headline": "Pfizer's 2025 Comeback: What's Driving Growth",
      "id": 132227410,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1491484031/image_1491484031.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Pfizer plans to achieve $4 billion in savings, invest in key areas like oncology and vaccines, and project double-digit EPS growth. Read more on PFE stock here.",
      "url": "https://finnhub.io/api/news?id=e57fd332ccd391b5d0c94cc57b5d0054cfa1b67004fe6029f2c8ff26b0384177"
    }
  },
  {
    "ts": null,
    "headline": "Drug-Trial Results Could Shake Up Pharma Stocks in 2025. Watch Eli Lilly, Pfizer, and More.",
    "summary": "For pharmaceutical stocks, there are few events as crucial as the results of clinical trials for new drugs.",
    "url": "https://finnhub.io/api/news?id=984f6cf4667c8292801aeb8ca49ba050a3881af711ca3316be8e22fcd3ce6d96",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735720200,
      "headline": "Drug-Trial Results Could Shake Up Pharma Stocks in 2025. Watch Eli Lilly, Pfizer, and More.",
      "id": 132225133,
      "image": "",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "For pharmaceutical stocks, there are few events as crucial as the results of clinical trials for new drugs.",
      "url": "https://finnhub.io/api/news?id=984f6cf4667c8292801aeb8ca49ba050a3881af711ca3316be8e22fcd3ce6d96"
    }
  }
]